Tools

LEADER 02380nam 2200517 i 4500

001 on1396571841;

003 OCoLC;

005 20230908123710.0;

006 m o d f ;

007 cr |||||||||||;

008 230908s2023 dcua ob f000 0 eng c;

035 a| (Sirsi) o1396571841;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-23-105656;

088 a| GAO-23-105656;

110 1 a| United States.b| Government Accountability Office,e| author.=| ^A580995;

245 10 a| National Institutes of Health :b| better data will improve understanding of federal contributions to drug development : report to congressional requesters /c| United States Government Accountability Office.;

246 30 a| Better data will improve understanding of federal contributions to drug development;

246 17 a| GAO-23-105656 NIH biomedical research;

264 1 a| Washington, DC :b| United States Government Accountability Office,c| 2023.;

300 a| 1 online resource (ii, 50 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "April 2023.";

500 a| "GAO-23-105656.";

500 a| In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

588 a| Description based on online resource; title from PDF title page (GAO, viewed September 8, 2023).;

610 20 a| National Institutes of Health (U.S.)x| Financex| Evaluation.=| ^A2368;

650 0 a| Pharmaceutical industryz| United Statesx| Finance.=| ^A638;

650 0 a| Drugsx| Researchz| United States.=| ^A1001118;

650 0 a| Drug developmentx| Government policyz| United States.=| ^A443888;

650 0 a| Drug developmentz| United Statesx| Finance.=| ^A443888;

650 0 a| Medical scientistsz| United States.=| ^A837619;

856 40 u| https://purl.fdlp.gov/GPO/gpo2163137| 0;

922 a| BIBCONEW 20230908;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6274191;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6274191-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 10/24/2023x| EDOCUMENTz| JERESOURCE;

National Institutes of Health : better data will improve understanding of federal contributions to drug development : report to congressional requesters / United States Government Accountability Office.

Author/creator	United States
Format	Electronic
Publication	Washington, DC : United States Government Accountability Office, 2023.
Description	1 online resource (ii, 50 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo216313
Subjects	National Institutes of Health (U.S.)--Finance. --Evaluation. Pharmaceutical industry--United States. --Finance. Drugs--Research. --United States. Drug development--Government policy. --United States. Drug development--United States. --Finance. Medical scientists--United States.

Portion of title	Better data will improve understanding of federal contributions to drug development
Running title	GAO-23-105656 NIH biomedical research
General note	"April 2023."
General note	"GAO-23-105656."
General note	In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource; title from PDF title page (GAO, viewed September 8, 2023).
Technical rpt number	GAO-23-105656
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-23-105656

National Institutes of Health : better data will improve understanding of federal contributions to drug development : report to congressional requesters / United States Government Accountability Office.

Click here for more information about this title